MARROW TRANSPLANTATION FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE AS TREATMENT FOR TRANSLOCATION (4:11) ACUTE LEUKAEMIA
- 1 September 1988
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 70 (1) , 127-128
- https://doi.org/10.1111/j.1365-2141.1988.tb02447.x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimenBlood, 1987
- Persistence of t(4;11) in cytologically normal bone marrow treated ex vivo with Asta-ZCancer Genetics and Cytogenetics, 1986
- Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemiaBlood, 1986
- The (4;11) translocation in acute leukaemia of childhood: the importance of additional chromosomal aberrationsBritish Journal of Haematology, 1985
- Translocation 4; 11 in acute lymphoblastic leukemia: clinical characteristics and prognostic significanceBlood, 1982